These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2066987)

  • 1. 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors.
    Knebel NG; von Angerer E
    J Med Chem; 1991 Jul; 34(7):2145-52. PubMed ID: 2066987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier mediated action of platinum complexes on estrogen receptor positive tumors.
    Knebel N; Schiller CD; Schneider MR; Schönenberger H; von Angerer E
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):293-9. PubMed ID: 2702983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
    von Angerer E; Erber S
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum complexes with binding affinity for the estrogen receptor.
    Knebel N; von Angerer E
    J Med Chem; 1988 Sep; 31(9):1675-9. PubMed ID: 3411596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
    Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
    J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure activity studies on leaving group derivatives of [meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] platinum(II).
    Gust R; Keilitz R; Krauser R; Schmidt K; Schnurr B
    Arch Pharm (Weinheim); 1999 Aug; 332(8):261-70. PubMed ID: 10489536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma.
    Karl J; Gust R; Spruss T; Schneider MR; Schönenberger H; Engel J; Wrobel KH; Lux F; Haeberlin ST
    J Med Chem; 1988 Jan; 31(1):72-83. PubMed ID: 3336035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity.
    von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W
    Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat.
    von Angerer E; Prekajac J; Strohmeier J
    J Med Chem; 1984 Nov; 27(11):1439-47. PubMed ID: 6492074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells.
    von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W
    Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the estrogenic side effects of the mammary tumor-inhibiting drug [1,2-bis(2,6-dichloro-4-hydroxyphenyl)- ethylenediamine]dichloroplatinum(II) by variation of ring substituents.
    Gust R; Karl J; Faderl M; Schönenberger H
    Arch Pharm (Weinheim); 1995 May; 328(5):457-63. PubMed ID: 7611841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.
    Gust R; Faderl M; Schönenberger H
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):647-54. PubMed ID: 11079729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumors.
    Erber S; von Angerer E
    Arch Pharm (Weinheim); 1990 Sep; 323(9):591-4. PubMed ID: 2288481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting properties.
    Schertl S; Gust R; Müller R; Spruss T; Schönenberger H
    Arch Pharm (Weinheim); 1992 Feb; 325(2):113-8. PubMed ID: 1605715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
    Biberger C; von Angerer E
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.
    Schuderer ML; Schneider MR
    J Cancer Res Clin Oncol; 1987; 113(3):230-4. PubMed ID: 3584214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.